408
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study*

, , , , , , , , , , , & show all
Pages 859-868 | Accepted 27 Jan 2009, Published online: 20 Feb 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christopher J Llop, Edward Tuttle, Glenn S Tillotson, Kerry LaPlante & Thomas M File$suffix/text()$suffix/text(). (2017) Antibiotic treatment patterns, costs, and resource utilization among patients with community acquired pneumonia: a US cohort study. Hospital Practice 45:1, pages 1-8.
Read now

Articles from other publishers (10)

Guoying Cao, Yongjun Zhu, Xin Xie, Yuancheng Chen, Jicheng Yu, Jing Zhang, Zhiming Chen, Liewen Pang, Yingyuan Zhang & Yaoguo Shi. (2020) Pharmacokinetics and pharmacodynamics of levofloxacin in bronchial mucosa and lung tissue of patients undergoing pulmonary operation. Experimental and Therapeutic Medicine 20:1, pages 607-616.
Crossref
Raquel K. Belforti, Tara Lagu, Sarah Haessler, Peter K. Lindenauer, Penelope S. Pekow, Aruna Priya, Marya D. Zilberberg, Daniel Skiest, Thomas L. Higgins, Mihaela S. Stefan & Michael B. Rothberg. (2016) Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia. Clinical Infectious Diseases 63:1, pages 1-9.
Crossref
Chi-Chuan Wang, Chia-Hui Lin, Kuan-Yin Lin, Yu-Chung Chuang & Wang-Huei Sheng. (2016) Comparative Outcome Analysis of Penicillin-Based Versus Fluoroquinolone-Based Antibiotic Therapy for Community-Acquired Pneumonia. Medicine 95:6, pages e2763.
Crossref
Simone Gattarello. (2015) What Is New in Antibiotic Therapy in Community-Acquired Pneumonia? An Evidence-Based Approach Focusing on Combined Therapy. Current Infectious Disease Reports 17:10.
Crossref
G. Cao, J. Zhang, X. Wu, J. Yu, Y. Chen, X. Ye, D. Zhu, Y. Zhang, B. Guo & Y. Shi. (2013) Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy C hinese volunteers and dosing regimen optimization . Journal of Clinical Pharmacy and Therapeutics 38:5, pages 394-400.
Crossref
L. Asadi, D.T. Eurich, J.M. Gamble, J.K. Minhas-Sandhu, T.J. Marrie & S.R. Majumdar. (2013) Impact of guideline-concordant antibiotics and macrolide/β-lactam combinations in 3203 patients hospitalized with pneumonia: prospective cohort study. Clinical Microbiology and Infection 19:3, pages 257-264.
Crossref
Timothy E. Albertson, Brian M. Morrissey & Andrew L. Chan. (2012) Are Fluoroquinolones Superior Antibiotics for the Treatment of Community-Acquired Pneumonia?. Current Infectious Disease Reports 14:3, pages 317-329.
Crossref
Christopher R. Frei, Matthew J. Labreche & Russell T. Attridge. (2011) Fluoroquinolones in Community-Acquired Pneumonia. Drugs 71:6, pages 757-770.
Crossref
Christopher R Frei, Eric M Mortensen, Laurel A Copeland, Russell T Attridge, Mary Jo V Pugh, Marcos I Restrepo, Antonio Anzueto, Brandy Nakashima & Michael J Fine. (2010) Disparities of Care for African-Americans and Caucasians with Community-Acquired Pneumonia: A Retrospective Cohort Study. BMC Health Services Research 10:1.
Crossref
Marcos I. Restrepo & Christopher R. Frei. (2010) Health Economics of Use Fluoroquinolones to Treat Patients with Community-Acquired Pneumonia. The American Journal of Medicine 123:4, pages S39-S46.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.